Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.39 |
| ▸ | P2RX3 | P56373 | 8/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.34 |
| ▸ | P2RX2 | Q9UBL9 | 6/20 | 0.34 |
| ▸ | TRPV3 | Q8NET8 | 3/20 | 0.33 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | IDH1 | O75874 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL998111 | 1.00 | GPR139 (0.40) | GPR139CYP2C9NR1I2TRPV4P2RX3 | |
| SCHEMBL996960 | 1.00 | GPR139 (0.40) | GPR139CYP2C9NR1I2TRPV4P2RX3 | |
| SCHEMBL19962272 | 1.00 | GPR139 (0.40) | GPR139CYP2C9NR1I2TRPV4P2RX3 | |
| SCHEMBL998112 | 1.00 | GPR139 (0.40) | GPR139CYP2C9NR1I2TRPV4P2RX3 | |
| SCHEMBL346582 | 1.00 | GPR139 (0.40) | GPR139CYP2C9NR1I2TRPV4P2RX3 | |
| SCHEMBL28656329 | 1.00 | GPR139 (0.40) | GPR139CYP2C9NR1I2TRPV4P2RX3 | |
| SCHEMBL28656330 | 1.00 | GPR139 (0.40) | GPR139CYP2C9NR1I2TRPV4P2RX3 | |
| SCHEMBL14831456 | 0.88 | IDH1 (0.36) | GPR139CYP2C9NR1I2IDH1 | |
| SCHEMBL14831455 | 0.88 | IDH1 (0.36) | GPR139CYP2C9NR1I2IDH1 | |
| SCHEMBL27966106 | 0.88 | IDH1 (0.36) | GPR139CYP2C9NR1I2IDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110256418-B | 1, 3-thiazol-2-yl substituted benzamides | 拜耳公司 | 2023-01-20 | — | — | CN | disclosed |
| CN-107207507-B | 1, 3-thiazol-2-yl substituted benzamides | 拜耳公司 | 2020-11-06 | — | — | CN | disclosed |
| EP-2358371-A1 | P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN | Merck Sharp & Dohme Corp. (US) | 2011-08-24 | — | — | EP | disclosed |
| EP-2215048-A1 | P2X3 RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN | Merck Sharp & Dohme Corp. (US) | 2010-08-11 | — | — | EP | disclosed |
| WO-2010051188-A1 | P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN | MERCK SHARP & DOHME CORP. (US) | 2010-05-06 | — | — | WO | disclosed |
| WO-2009058299-A1 | P2X3 RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN | MERCK & CO., INC. (US) | 2009-05-07 | — | — | WO | disclosed |